Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityNo recent work listed

Changyu Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8656-0428; OpenAlex author ID A5100769181. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vit… Co-author DOI 10.1016/j.jep.2023.116198↗
  2. Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.1097/md.0000000000003098↗
  3. Transarterial infusion with gemcitabine and oxaliplatin for the treatment of unresectable pancreatic cancer. Last author DOI 10.1097/cad.0000000000000120↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Libin Song · 1 shared paper, 2023 · strength 0.18
  2. Xuming Ji · 1 shared paper, 2023 · strength 0.18
  3. Xiang Qian · 1 shared paper, 2023 · strength 0.18
  4. Luming Liu · 1 shared paper, 2023 · strength 0.18
  5. Xiaolin Wang · 2 shared papers, 2014–2016 · strength 0.11
  6. Xiaoyu Liu · 1 shared paper, 2016 · strength 0.07
  7. Guofeng Zhou · 1 shared paper, 2016 · strength 0.07
  8. Yi Chen · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.